Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
35 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

Science


RSS FeedsNucala (mepolizumab) study reports long-term safety data, consistent exacerbation reduction and improved asthma control
(World News Science)

 
 

21 may 2018 11:24:57

 
Nucala (mepolizumab) study reports long-term safety data, consistent exacerbation reduction and improved asthma control
(World News Science)
 


GlaxoSmithKline plc (GSK) today presented new data from the longest study of an anti-IL5 biologic treatment in severe eosinophilic asthma to be reported. The study showed consistent reductions in exacerbations and improvements in asthma control, with a safety profile similar to previous clinical studies, in severe eosinophilic asthma patients treated with Nucala (mepolizumab) over the long-term study period. One third of patients in the study treated with mepolizumab experienced no exacerbations, despite entering the study with an average of almost two exacerbations (1.74) per year. The open-label COLUMBA study, presented at the American Thoracic Society (ATS) conference, is a long-term...


 
124 viewsCategory: Science
 
White paper released on China`s blockchain technology
(World News Science)
INV Final ESOP share buy-back notice - Appendix 3F
(World News Science)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten